Search clinical trials for: Seroquel and Risperidone

Total 270311 results

AstraZeneca

Completed

Safety and Efficacy of Seroquel in First Episode Schizophrenia

Schizophrenia

United Kingdom
Shanghai Mental Health Center

Completed

A Study to Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With Schizophrenia

Schizophrenia

China
AstraZeneca

Completed

A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
University of Texas Southwestern Medical Center

Completed

Quetiapine for Bipolar Disorder and Alcohol Dependence

Alcohol Dependence | Bipolar Disorder

United States
University of Texas Southwestern Medical Center
Stanley Medical Research Institute; University of North Texas Health Science...

Completed

A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence

Bipolar Disorder | Cocaine Dependence | Methamphetamine Dependence

United States
AstraZeneca

Completed

Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in Patients With Stable Schizophrenia (eXtRa)

Schizophrenia

Italy, Germany, Austria, Spain, Denmark
University of British Columbia
Bristol-Myers Squibb

Completed

Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI (CALM)

Psychotic Disorders | Bipolar Disorder | Metabolic Syndrome X

Canada
AstraZeneca

Completed

Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder (UNIQUE)

Major Depressive Disorder

Belgium
Rovi Pharmaceuticals Laboratories

Completed

Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle (ISM)® in Patients With Acute Schizophrenia (PRISMA-3)

Acute Schizophrenia

United States, Ukraine
Indiana University School of Medicine
AstraZeneca

Completed

Brain Imaging of Quetiapine Response in Anxious Depression

Major Depression

United States
University of Pittsburgh
Janssen Pharmaceuticals

Completed

Risperdal Consta for Bipolar Disorder

Bipolar I Disorder

United States
AstraZeneca

Terminated

Seroquel XR in Adults With Schizophrenia

Schizophrenia

Thailand
BC Women's Hospital & Health Centre

Completed

Quetiapine in the Treatment of Postpartum Depression (PPD) in Bipolar Disorder (BD), Type II

Postpartum Depression

Canada
Sunnybrook Health Sciences Centre
AstraZeneca

Completed

Identifying Very Early Response to Seroquel Extended Release (XR) Augmentation for Major Depressive Disorder

Depressive Disorder, Major

Canada
AstraZeneca

Completed

Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone (RECOVER)

Schizophrenic Disorders

Brazil, Bulgaria, Russian Federation, Turkey, Germany, Romania, Finland, Belgium, Italy, Portugal, Mexico, Spain, Costa Rica, Switzerland
AstraZeneca

Terminated

Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose

Schizophrenic Disorders

Finland
AstraZeneca

Terminated

Study of the Broad Clinical Benefit for Seroquel XR With Flexible Dose as an add-on Therapy in the Treatment of Acute Bipolar Mania Patients With Partial Response to Current Therapy (RELEASE)

Acute Bipolar Mania

Korea, Republic of
Northwestern University
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone

Schizophrenia | Schizoaffective Disorder

United States
Zogenix, Inc.

Completed

A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia

Schizophrenia

United States
AstraZeneca

Completed

Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia

Schizophrenia

Malaysia
Rovi Pharmaceuticals Laboratories

Completed

Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths (PRISMA-1)

Schizophrenia | Schizoaffective Disorder

Spain, South Africa, Russian Federation, Croatia
Zogenix, Inc.

Completed

Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
University of Regensburg
AstraZeneca

Completed

Quetiapine Induced Neuroplasticity in First-episode Schizophrenic Patients

Schizophrenia

Germany
AstraZeneca

Completed

Quetiapine Extended Release Depression Symptoms (ExAttitude)

Depression | Schizophrenia

Italy
AstraZeneca

Completed

SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia

Schizophrenic Disorder

Bulgaria, Russian Federation, Romania, South Africa, Greece, Philippines, India, Indonesia
Washington University School of Medicine
National Institute of Mental Health (NIMH)

Completed

Glucose and Lipid Metabolism on Antipsychotic Medication (Glulipid)

Hyperglycemia | Schizophrenia | Schizoaffective Disorder | Type 2 Diabetes Mellitus

United States
Northwell Health

Terminated

1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain

High Risk MC4R Genotype | Low Risk MC4R Genotype | One Week or Less Antipsychotic Lifetime Exposure

United States
Xijing Hospital

Unknown

Repetitive Transcranial Magnetic Stimulation for First-episode Schizophrenia Patients (rTMSfMRI)

Schizophrenia

China
Janssen-Cilag S.p.A.

Completed

Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder
Severance Hospital

Unknown

Effects of 'Seroquel-XR' on the Improvement of Neurocognitive Function in People At-risk Mental States(ARMS) (ES-ARMS)

Schizophrenia | Abnormal Mental State

Korea, Republic of
AstraZeneca

Completed

Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression

Bipolar Depression
Indiana University
AstraZeneca

Completed

A Study of Quetiapine SR (Seroquel SR) to Treat SSRI-Resistant, Comorbid Panic Disorder Patients

Panic Disorder

United States
Lone Baandrup
University of Copenhagen; Glostrup University Hospital, Copenhagen; Danish Center... and other collaborators

Recruiting

Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use

Dual Diagnosis

Denmark
University of Alabama at Birmingham

Withdrawn

Impulsivity and Thought Process Disorder in Patients With Active Suicidal Ideation and Depression

Depression | Impulsivity | Active Suicidal Ideation

United States
University Hospitals Cleveland Medical Center
National Alliance for Research on Schizophrenia and Depression; AstraZeneca

Completed

Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)

Anxiety Disorders | Anxiety | Bipolar Disorder | Substance Use Disorders

United States
Rovi Pharmaceuticals Laboratories

Recruiting

Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia (QUARTZ)

Schizophrenia

Jordan
Inje University

Unknown

The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope

Major Depressive Disorder

Korea, Republic of
Hoffmann-La Roche

Completed

A Study of the Combination of Multiple Doses of RO5285119 With a Single Dose of Risperidone in Healthy Volunteers

Healthy Volunteer

France
University Hospital Muenster
AstraZeneca

Completed

Quetiapine in Specific Phobia (QUISS)

Specific Phobia

Germany
Changhua Christian Hospital

Terminated

Risperidone and Zotepine in the Treatment of Delirium

Delirium

Taiwan
Janssen Korea, Ltd., Korea

Completed

An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective Disorder

Schizophrenia

Korea, Republic of
Rovi Pharmaceuticals Laboratories

Completed

Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension (PRISMA-3_OLE)

Schizophrenia

United States, Ukraine
Hospital Sao Domingos

Not yet recruiting

Evaluation of the Perception of Quality of Care of Patients Admitted to a Medical-Surgical ICU

Critically Ill
Dartmouth-Hitchcock Medical Center
Janssen, LP

Completed

Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder

Psychotic Disorders | Schizophrenia | Substance Abuse | Alcohol Abuse

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder

Autistic Disorder | Autism

United States
Janssen Cilag N.V./S.A.

Completed

A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode

Schizophrenia

South Africa
Xian-Janssen Pharmaceutical Ltd.

Withdrawn

Bioequivalence Study of Xian Risperdal Tablets Compared With Gurabo Risperdal Tablets Under Fasting and Fed Conditions in Chinese Healthy Participants

Healthy

China
VA Office of Research and Development
University of Colorado, Denver

Withdrawn

Nicotinic Receptors and Schizophrenia

Schizophrenia

United States
Yale University
Steven & Alexandra Cohen Foundation

Recruiting

Effects of Repeated Psilocybin Dosing in OCD

Obsessive-Compulsive Disorder

United States
University of California, Los Angeles
National Institute of Mental Health (NIMH); Janssen Scientific Affairs, LLC

Completed

Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia

Schizophrenia

United States

Search clinical trials for: Seroquel and Risperidone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations